The relationship between Activin A and anti-angiogenic factors in the development of pre-eclampsia

Research output: Contribution to journalArticleResearchpeer-review

11 Citations (Scopus)

Abstract

Anti-angiogenic factors such as sFlt/sEng contribute to the pathology seen in preeclampsia. Activin A, which is released by the placenta following exposure to oxidative stress and elevated in preeclampsia, may interact with sFlt/sEng during the disease process. Using placental explant cultures, we determined that transcription of sFLT1, ENG and INHBA was upregulated following exposure to oxidative stress or IL-6. Explants treated with Activin A did not increase transcription of sFLT1, ENG. Conversely, treatment of placental explants with sFlt/sEng did not increase transcription of INHBA. These data may suggest that Activin A and sFlt/sEng contribute to preeclampsia via separate pathways. ? 2013 International Society for the Study of Hypertension in Pregnancy.
Original languageEnglish
Pages (from-to)3 - 6
Number of pages4
JournalPregnancy Hypertension
Volume4
Issue number1
DOIs
Publication statusPublished - 2014

Cite this

@article{0a403d2b2c6e406895a5f7481792644a,
title = "The relationship between Activin A and anti-angiogenic factors in the development of pre-eclampsia",
abstract = "Anti-angiogenic factors such as sFlt/sEng contribute to the pathology seen in preeclampsia. Activin A, which is released by the placenta following exposure to oxidative stress and elevated in preeclampsia, may interact with sFlt/sEng during the disease process. Using placental explant cultures, we determined that transcription of sFLT1, ENG and INHBA was upregulated following exposure to oxidative stress or IL-6. Explants treated with Activin A did not increase transcription of sFLT1, ENG. Conversely, treatment of placental explants with sFlt/sEng did not increase transcription of INHBA. These data may suggest that Activin A and sFlt/sEng contribute to preeclampsia via separate pathways. ? 2013 International Society for the Study of Hypertension in Pregnancy.",
author = "Seshini Gurusinghe and Wallace, {Euan Morrison} and Lim, {Rebecca Seok Wai}",
year = "2014",
doi = "10.1016/j.preghy.2013.09.002",
language = "English",
volume = "4",
pages = "3 -- 6",
journal = "Pregnancy Hypertension",
issn = "2210-7789",
publisher = "Elsevier",
number = "1",

}

The relationship between Activin A and anti-angiogenic factors in the development of pre-eclampsia. / Gurusinghe, Seshini; Wallace, Euan Morrison; Lim, Rebecca Seok Wai.

In: Pregnancy Hypertension, Vol. 4, No. 1, 2014, p. 3 - 6.

Research output: Contribution to journalArticleResearchpeer-review

TY - JOUR

T1 - The relationship between Activin A and anti-angiogenic factors in the development of pre-eclampsia

AU - Gurusinghe, Seshini

AU - Wallace, Euan Morrison

AU - Lim, Rebecca Seok Wai

PY - 2014

Y1 - 2014

N2 - Anti-angiogenic factors such as sFlt/sEng contribute to the pathology seen in preeclampsia. Activin A, which is released by the placenta following exposure to oxidative stress and elevated in preeclampsia, may interact with sFlt/sEng during the disease process. Using placental explant cultures, we determined that transcription of sFLT1, ENG and INHBA was upregulated following exposure to oxidative stress or IL-6. Explants treated with Activin A did not increase transcription of sFLT1, ENG. Conversely, treatment of placental explants with sFlt/sEng did not increase transcription of INHBA. These data may suggest that Activin A and sFlt/sEng contribute to preeclampsia via separate pathways. ? 2013 International Society for the Study of Hypertension in Pregnancy.

AB - Anti-angiogenic factors such as sFlt/sEng contribute to the pathology seen in preeclampsia. Activin A, which is released by the placenta following exposure to oxidative stress and elevated in preeclampsia, may interact with sFlt/sEng during the disease process. Using placental explant cultures, we determined that transcription of sFLT1, ENG and INHBA was upregulated following exposure to oxidative stress or IL-6. Explants treated with Activin A did not increase transcription of sFLT1, ENG. Conversely, treatment of placental explants with sFlt/sEng did not increase transcription of INHBA. These data may suggest that Activin A and sFlt/sEng contribute to preeclampsia via separate pathways. ? 2013 International Society for the Study of Hypertension in Pregnancy.

UR - http://www.sciencedirect.com/science/article/pii/S2210778913002092

U2 - 10.1016/j.preghy.2013.09.002

DO - 10.1016/j.preghy.2013.09.002

M3 - Article

VL - 4

SP - 3

EP - 6

JO - Pregnancy Hypertension

JF - Pregnancy Hypertension

SN - 2210-7789

IS - 1

ER -